Distinct phenotypic and urine biological characteristics are seen for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with a history of ulcerative Hunner lesions (UIC) and those ...

(HealthDay News) — Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online in the International Journal of Urology.

Onabotulinumtoxin A is under clinical development by AbbVie and currently in Phase III for Unspecified Musculoskeletal Disorders.

Discover a recent study that revealed that interstitial cystitis patients were older, predominantly female, and exhibited ...

A health and wellness company focused on meeting the needs of the underserved and aiding people across the world with ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Biomarkers, such as proteins found in blood or urine, indicate biological processes at work in ... all-cause and lung cancer-specific mortality is significantly reduced in patients tested for ...

Millions of Brits can skip the GP queue this winter and head straight to their local pharmacist. Amid warnings a ‘quad-emic’ of flu, covid, RSV and norovirus, doctors and hospital medics are battling ...

Introduction Recurrent urinary tract infections (RUTIs ... lactating or planning pregnancy during the course of the study; formal diagnosis of interstitial cystitis or overactive bladder syndrome; ...